Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 508 of 6351
-
Could a daily aspirin save lives after pneumonia in the elderly?
Disease control Not yet recruitingAcute pneumonia is a very common disease, and one of the leading causes of hospitalization and death in France. Almost a century after the discovery of penicillin, no major breakthrough has significantly reduced pneumonia-related mortality. While the choice of an appropriate anti…
Phase 3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Jun 26, 2026 16:25 UTC
-
Can a shorter steroid course save preemie lungs?
Prevention Not yet recruitingThe goal of this clinical trial is to compare the effectiveness of two different dexamethasone treatment regimens (the DART regimen and the medium-dose tapering regimen) in reducing the incidence of Bronchopulmonary Dysplasia (BPD) or death by 36 weeks of postmenstrual age in pre…
Phase 3 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Prevention
Last updated Jun 27, 2026 07:59 UTC
-
Kenya project aims to eradicate cervical cancer with HPV vaccine and better screening
Prevention Not yet recruitingThis project serves to continue a community-based initiative, known as the Kenya Mother-Daughter Cervical Cancer Eradication Project, or the Mother-Daughter Project (MDP), in the Webuye region of Western Kenya. The MDP project, since its initiation in 2018, has sought to develop …
Sponsor: Indiana University • Aim: Prevention
Last updated Jun 27, 2026 08:11 UTC
-
Could laughing gas lift the fog of depression?
Symptom relief Not yet recruitingMulti-centre, parallel group, blinded, 1:1 randomized controlled trial to determine the effect of nitrous oxide on reducing symptoms of depression in patients with treatment resistant depression.
Phase 3 • Sponsor: Women's College Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
AI-ECG could catch deadly lung condition before It's too late
Diagnosis Recruiting nowThis study aims to validate the use of an artificial intelligence-enabled electrocardiogram (AI-ECG) to screen for elevated PAP. We hypothesize that the AI-ECG model can early identify patients with pulmonary hypertension in high-risk patients, prompting further evaluation throug…
Sponsor: National Defense Medical Center, Taiwan • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
New drug aims to save lives from shock due to blood loss
Disease control Not yet recruitingThis protocol is designed to develop a novel first-in-class treatment for use in critical care and life-threatening condition of hypovolemic shock with unmet need and is of national interest. Shock is a life-threatening condition of circulatory failure. It is a state of cellular …
Phase 3 • Sponsor: Pharmazz, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Robots vs. laparoscopy: which surgery beats stomach cancer?
Disease control Not yet recruitingThe goal of this multicenter, randomized, phase III clinical trial is to test whether robot-assisted radical gastrectomy improves 3-year recurrence-free survival versus laparoscopy-assisted radical gastrectomy in adults aged 18-80 years with previously untreated, resectable cT4a …
Phase 3 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New Three-Drug cocktail aims to tackle Hard-to-Treat multiple myeloma
Disease control Not yet recruitingDespite advances in multiple myeloma (MM) therapy, patients continue to suffer from frequent relapses and treatment-resistant disease. Therefore, additional novel, safe, and effective therapies are needed to drive deeper and more prolonged responses for patients with RRMM. Mezig…
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New study tailors surgery and radiation to each Patient's response in advanced breast cancer
Disease control Recruiting nowThe goal of this interventional clinical trial is to evaluate if an individualized treatment strategy (involving radiation boost, surgery, and systemic consolidation) can improve progression-free survival in patients with breast cancer presenting with positive ipsilateral supracl…
Phase 2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New hope: immune drug before surgery for tough colorectal cancer
Disease control Recruiting nowThis study is a prospective, observational, real-world investigation. This study will evaluate the efficacy and safety of tislelizumab monotherapy before surgery in patients with mismatch repair deficient or microsatellite instability high (dMMR/MSI-H) locally advanced colorectal…
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New drug cocktail aims to fight Hard-to-Treat throat cancer
Disease control Not yet recruitingThis study was designed to compare the efficacy and safety of Becotatug Vedotin (MRG003) combined with Pucotenlimab as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma.
Phase 2 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Can a diabetes drug stop prediabetes in its tracks?
Disease control Not yet recruitingPrediabetes is a precursor to diabetes, but compared with diabetes, much less is known about prediabetes. Prediabetes is defined based on a blood sample measuring long-term average glucose levels. In the Danish population, about 7% have prediabetes, and roughly one in five will d…
Phase 3 • Sponsor: Michael Mæng • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Radioactive beads could make liver tumors operable for colorectal cancer patients
Disease control Not yet recruitingThis is a observational, prospective, single arm, proof of concept study to assess safety, feasibility, and potential efficacy of combining Yttrium-90 transarterial radioembolization(TARE) with standard systemic therapy in clinical practice for potentially resectable patients wit…
Sponsor: Fernando Gómez Muñoz • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New study aims to cut Alzheimer's diagnosis wait time by nearly a year
Diagnosis Not yet recruitingThe BioMIND (Biomarkers for the Molecular Identification of Neurodegenerative Dementia) pilot study was launched at Parkwood Hospital in response to national calls for implementation of biomarker diagnostics in Canada. It evaluated the feasibility, impact, and equity of introduci…
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Diagnosis
Last updated Jun 27, 2026 09:05 UTC
-
New hope for NMOSD attacks: immune drug added to standard care
Disease control Recruiting nowThis project is a multi-center, prospective, real-world cohort study that collects clinical data of Chinese patients with AQP4-positive NMOSD in the acute stage. It comprehensively assesses the clinical outcomes of the patients and aims to compare the clinical efficacy and safety…
Phase 4 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Heart attack survivors: new study seeks safer, smarter drug plan after stents
Disease control Not yet recruiting" Patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) with drug-eluting stents (DES) require optimized medical therapy to prevent recurrent cardiovascular events. This includes both antiplatelet and lipid-lowering strategies. For antip…
Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New drug combo aims to keep High-Risk leukemia in remission before transplant
Disease control Recruiting nowThe goal of this clinical trial is to compare the efficacy and safety of a venetoclax-based consolidation therapy versus conventional consolidation chemotherapy in newly diagnosed adult patients with high-risk acute myeloid leukemia (AML) who have achieved complete remission (CR)…
Phase 2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Heart-Saving pills? diabetes drugs tested to shield breast cancer patients from chemo damage
Prevention Not yet recruitingBackground: Breast cancer is the most frequently diagnosed malignancy among women worldwide and a major cause of morbidity and mortality. Anthracycline-based chemotherapy, particularly doxorubicin, remains a cornerstone of treatment; however, its clinical utility is limited by d…
Phase 4 • Sponsor: Tanta University • Aim: Prevention
Last updated Jun 27, 2026 09:09 UTC
-
Fasting diet and exercise may boost chemo in aggressive breast cancer
Disease control Recruiting nowLESLIE is a multicentric randomized controlled trial in patients with triple negative breast cancer receiving neoadjuvant chemo/immunotherapy (NAT). This trial investigates the hypothesis that adding a cyclic fasting-mimicking diet combined with exercise during the NAT improves t…
Phase 2 • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Citrus flavonoid hesperidin put to the test as a brain booster for overweight adults
Disease control Recruiting nowA randomized, double-blind, placebo-controlled trial was designed to test whether two doses of hesperidin (a natural flavonoid from citrus fruits) improve cognitive function in overweight and obese older adults. A total of 105 participants, aged 55-75 years with a BMI ≥24 kg/m² …
Sponsor: Min Hou • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC